ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2685

Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project

Arissa Young1, Kristofer Andreasson2, Swapna Joshi3, Jen Labus3, Andrea Low Hsiu Ling4, vanessa smith5, Zsuzsanna McMahan6, Antonia Valenzuela Vergara7, Susanna Proudman8, Grace Kim3, Gracijela Bozovic2, Jonathan Goldin3, Ezinne Aja3, Jonathan Jacobs3 and Elizabeth Volkmann9, 1UCLA, Los Angeles, CA, 2Lund University, Lund, Sweden, 3UCLA, Los Angeles, 43Singapore General Hospital, Duke-NUS, Singapore, Singapore, 5Ghent University Hospital, Gent, Belgium, 6UTHealth Houston Division of Rheumatology, Houston, TX, 7Pontificia Universidad Catolica de Chile, Santiago, Chile, 8Royal Adelaide Hospital, Adelaide, Australia, 9University of California, Department of Medicine, Los Angeles, CA, USA, Los Angeles

Meeting: ACR Convergence 2024

Keywords: Imaging, interstitial lung disease, microbiome, Scleroderma, Systemic

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 19, 2024

Title: Abstracts: Systemic Sclerosis & Related Disorders – Clinical III

Session Type: Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Variations in gastrointestinal (GI) microbial communities may influence the development of lung diseases. Patients with SSc-ILD have a unique intestinal microbial signature. To further understand the gut-lung axis in SSc, this study aimed to investigate GI microbial correlates of distinct radiological features of ILD in a multicenter study.

Methods: SSc patients with and without ILD were recruited from 7 international SSc Centers (University of California, Los Angeles [UCLA], USA; Lund University [LU], Sweden; Duke-National University of Singapore, Singapore; Johns Hopkins University, USA; Ghent University, Belgium; University of Adelaide, Australia; Pontificia Universidad Católica de Chile, Chile) and provided a stool sample. Shotgun metagenomics were performed using the Illumina NovaSeq 6000 with a target depth of 10 million 150×2 sequences per sample. Shotgun reads were inputted into MetaPhlAn4 for taxonomic identification of species for compositional analysis and subsequently underwent center log-ratio transformation. High-resolution computed tomography (HRCT) scans of the chest underwent quantitative image analysis to determine the radiological extent of fibrosis (QLF) and ground glass opacity (QGG) in patients from UCLA and LU. General linear models were applied to identify differentially abundant species based on ILD presence and determine associations between QLF/QGG scores and species abundance, adjusting for body mass index, current proton pump inhibitor use, current probiotic use, current or prior immunomodulatory therapy, presence of small intestinal bacterial overgrowth and site. We considered p< 0.05 at the threshold for reporting and provide 5% false discovery rate corrected p-values (q). We also computed effect size estimates, Cohen’s D for mean differences and standardized Beta for association analyses.

Results: Among 285 participants with SSc, 62.5% had any ILD on HRCT. The mean age was 54.6 (SD 13) years and the median disease duration was 6.8 (IQR 3.5, 12.9) years. Among the 254 species analyzed, the abundance of 11 bacterial species was altered in patients with ILD compared to patients without ILD in all study participants, including Paraprevotella clara, which was increased in patients with ILD (Effect size 0.32 [95% CI 0.06, 0.58; P=0.02; q=0.94) and Sellimonas intestinalis, which was decreased in patients with ILD compared to without (Effect size -0.29 [95% CI -0.55, -0.03; P=0.03; q=0.94). In a multivariable analysis of 113 SSc-ILD patients, the abundance of 16 bacterial species correlated with QLF scores (Figure 1), while abundance of 18 bacterial species correlated with QGG scores (Figure 2). While some species (N=7) were associated with both QGG and QLF scores, 9 and 11 unique species were solely associated QLF and QGG scores, respectively (Table 1).

Conclusion: This multicenter study demonstrates that unique bacterial species are linked to radiological measures of fibrosis and ground glass opacity in SSc. These species and/or their metabolic products may contribute to the pathogenesis of these structural lung changes and may represent novel treatment targets.

Supporting image 1

Supporting image 2

Figure 1. Relationship between species abundance (Y-axis) and QLF score (X-axis) based on generalized linear model estimates (Red=Lund University; Blue=UCLA; N=113). The models adjusted for BMI, PPI use, Probiotic use, Immunomodulatory medication use, SIBO and study site.

Supporting image 3

Figure 2. Relationship between species abundance (Y-axis) and QGG score (X-axis) based on generalized linear model estimates (Red=Lund University; Blue=UCLA; N=113). The models adjusted for BMI, PPI use, Probiotic use, Immunomodulatory medication use, SIBO and study site.


Disclosures: A. Young: None; K. Andreasson: Janssen, 6; S. Joshi: None; J. Labus: None; A. Low Hsiu Ling: Boehringer-Ingelheim, 1, 5, 6; v. smith: Argenx, 2, BKC Moving Media Makers, 6, Boehringer-Ingelheim, 2, 5, 6, Janssen, 2, 5, 6, WebMDD Global LLC, 2; Z. McMahan: Boehringer-Ingelheim, 2; A. Valenzuela Vergara: None; S. Proudman: Boehringer-Ingelheim, 5, 6, Janssen, 5, 6; G. Kim: UCLA, 10, Voiant, 2; G. Bozovic: None; J. Goldin: MedQIA, 12, Founder; E. Aja: None; J. Jacobs: None; E. Volkmann: AbbVie, 2, Boehringer-Ingelheim, 2, 5, 6, GSK, 2, 5, Horizon, 5, Kadmon, 5, Prometheus, 5.

To cite this abstract in AMA style:

Young A, Andreasson K, Joshi S, Labus J, Low Hsiu Ling A, smith v, McMahan Z, Valenzuela Vergara A, Proudman S, Kim G, Bozovic G, Goldin J, Aja E, Jacobs J, Volkmann E. Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/association-between-gastrointestinal-bacterial-species-and-radiological-features-of-systemic-sclerosis-interstitial-lung-disease-ssc-ild-a-multicenter-study-from-the-ssc-microbiome-consortium-proje/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-gastrointestinal-bacterial-species-and-radiological-features-of-systemic-sclerosis-interstitial-lung-disease-ssc-ild-a-multicenter-study-from-the-ssc-microbiome-consortium-proje/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology